Combination of B7H6-siRNA and temozolomide synergistically reduces stemness and migration properties of glioblastoma cancer cells.
Sign Up to like & getrecommendations! Published in 2023 at "Experimental cell research"
DOI: 10.2139/ssrn.4148155
Abstract: Glioblastoma multiforme (GBM) is among the malignant brain tumors of the central nervous system (CNS). The survival of this disease is about 14 months after diagnosis. To date, temozolomide is known as first-line therapy for… read more here.
Keywords: glioblastoma cancer; b7h6 sirna; sirna temozolomide; combination ... See more keywords